United Kingdom

Showing 31-36 of 36 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Sotagliflozin in Patients with Heart Failure Symptoms and Type 1 Diabetes (SOPHIST)	University of Dundee	Ify Mordi	Improving Lives	01-September-2023 to 31-August-2026	$1.783.962,00
Developing The Translational Potential Of The NPY Y4 Receptor For Treating Type 1 Diabetes	King's College London	Gavin Bewick	Cures	01-June-2022 to 30-November-2026	$960.119,92
T1D Plus: a clinical trial platform for combined beta cell preservation therapy	Cardiff University	Colin Dayan	Cures	01-September-2022 to 31-August-2026	$2.605.623,32
Testing the feasibility and acceptability of EarLy Surveillance for Autoimmune diabetes: The ELSA Study	University of Birmingham	Parth Narendran	Cures	01-March-2022 to 31-August-2025	$585.569,82
Semaglutide as an add-on treatment to optimise glycaemic control in children and young people with type 1 diabetes	University of Birmingham	Timothy Barrett	Improving Lives	01-March-2023 to 28-February-2026	$1.782.815,00
Harmonizing biomarkers in clinical trials of ustekinumab	King's College London	Timothy Tree	Cures	01-July-2018 to 31-December-2025	$727.837,00